BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Study highlights Antengene's complementary focus on diseases with a higher prevalence in China

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and ...

January 03, 2022 | News

Ascletis Expands Ritonavir Oral Tablet Production

Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...

January 03, 2022 | News

First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...

December 29, 2021 | News

Biosyngen to commercialize immune cell therapeutics in China

The inauguration ceremony of Biosyngen Pte. Ltd., ("Biosyngen") joint projects and Biosyngen biological production base was held in China-Singapore&nb...

December 29, 2021 | News

Scientists from A*STAR GIS awarded CZI Ancestry Network Grant to investigate immune diversity in Singapore and Asia

A team of researchers, led by the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), was awarded the p...

December 20, 2021 | News

Singular Genomics Launches the G4 Sequencing Platform

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

December 17, 2021 | News

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Volition's global strategy is to implement similar agreements with multiple companies to ensure the broadest possible accessibility to the Nu.Q® ...

December 17, 2021 | News

Noorik Biopharmaceuticals announces contract for ambrisentan treatment of COVID-19

Noorik Biopharmaceuticals Ltd. ("Noorik"), a clinical-stage biopharmaceutical company repurposing micro-dose ambrisentan for the treatment of kidney, liver...

December 16, 2021 | News

Hyris presents new T-Cell test detecting immune responses to SARS-CoV-2

Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunolo...

December 16, 2021 | News

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...

December 15, 2021 | News

Samsung Biologics , AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

The partnership is based on an expanded deal this year in May 2021 which followed the signing of a long-term strategic agreement made in Sep...

December 14, 2021 | News

Scientists discover and name novel gene that governs left-right asymmetry within the human body

A team of researchers, led by the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), in collaboration ...

December 14, 2021 | News

HKU microbiology researchers collaborating with vaccine manufacturers

After successfully isolating the SARS-CoV-2 Omicron variant from clinical specimens, researchers at the Department of Microbiology at The University of Hon...

December 14, 2021 | News

Stay Connected